Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3M Buy
+235,459
New +$12.5M 6.54% 6
2025
Q2
Sell
-90,659
Closed -$3.51M 12
2025
Q1
$3.51M Buy
90,659
+29,047
+47% +$1.06M 3.25% 5
2024
Q4
$2.08M Buy
+61,612
New +$2.22M 2.56% 5

Other funds holding GSK

SALT Holding Corp's GSK Position: Q2 2026 in Review

SALT Holding Corp opened a new position in GSK (GSK) in Q2 2026: 235,459 shares worth $12.3M. The stake represents 6.54% of the portfolio and ranks #6 among its holdings. This is a return to the name: SALT Holding Corp previously reported a position in GSK as recently as Q1 2025.

SALT Holding Corp first reported a position in GSK in Q4 2024 and has held it in 3 quarters since. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • SALT Holding Corp held 235,459 shares of GSK worth $12.3M as of Q2 2026.
  • GSK was a new SALT Holding Corp position in Q2 2026.
  • GSK made up 6.54% of SALT Holding Corp's portfolio in Q2 2026, its #6 holding.
  • SALT Holding Corp first reported a position in GSK in Q4 2024 and has held it in 3 quarters since.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on SALT Holding Corp's 13F filing for Q2 2026, filed 14 Aug 2026.